Circadian variation in methotrexate toxicity in streptozotocin-induced diabetes mellitus rats

References

• Balis , F M , Jeffries , S L , Lange , B , Murphy , R F , Doherty , K M , Arndt , C A , Luery , N and Poplack , D G . 1989 . Chronopharmacokinetics of oral methotrexate and 6-mercaptopurine: is there diurnal variation in the disposition of antileukemic therapy? . Am J Pediatr Hematol Oncol , 11 : 324 – 326 .
   PubMedGoogle Scholar
• Bjarnason , G A . 1995 . Clinical chronotolerance to anticancer drugs: relevance for dose-intensity . In vivo , 9 : 557 – 564 .
   PubMedGoogle Scholar
• English , J , Aherne , G W , Arendt , J and Marks , V . 1987 . The effect of abolition of the endogenous corticosteroid rhtyme on the circadian variation in methotrexate toxicity in the rat . Cancer Chemother Pharmacol , 19 : 287 – 290 .
   PubMed Web of Science ®Google Scholar
• Eriksson , U , Ewald , U and Tuvemo , T . 1983 . Increased platelet volume in manifest diabetic rats . Ups J Med Sci , 88 : 17 – 23 .
   PubMed Web of Science ®Google Scholar
• Ferrazzini , G , Sohl , H and Robieux , I . 1991 . Diurnal variations of methotrexate disposition in children with acute leukemia . Eur J Clin Pharmacol , 41 : 425 – 427 .
   PubMed Web of Science ®Google Scholar
• Gwilt , P R , Nahhas , R R and Tracewell , W G . 1991 . The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans . Clin Pharmacokinet , 20 : 477 – 490 .
   PubMed Web of Science ®Google Scholar
• Gumustekin , M , Kalkan , S , Murat , N , Gur , O , Hocaoglu , N and Gidener , S . 2005 . The role of circadian rhythm on the pharmacokinetic of methotrexate in streptozotocin-induced diabetes mellitus rats . Biol Rhythm Res , 36 : 277 – 285 .
   Web of Science ®Google Scholar
• Hruesky , W JM and Bjarnason , G A . 1993 . Circadian cancer therapy . J Clin Oncol , 1 : 1403 – 1407 .
   Google Scholar
• Jansen , G , Mauritz , R M , Assaraf , Y G , Sprecher , H , Stavit , D , Kathman , Westerhof , R , Priest , D G , Bunni , M , Pinedo , H M , Schornagel , J H and Peters , G J . 1997 . Regulation of carrier mediated transport of folates and antifolates in methotrexate-sensitive and resistant leukemia cells . Advan Enzyme Regul , 37 : 59 – 76 .
   PubMedGoogle Scholar
• Judge , S , Mammen , E and Dunbar , J C . 1995 . The effect of streptozocin-induced diabtes on platelet aggregation as determined by impedance aggregometry and platelet secretion: a possible role for nitric oxide . J Assoc Acad Minor Phsy , 6 : 100 – 104 .
   PubMedGoogle Scholar
• Kim , S H , Kim , W B and Lee , M G . 1998 . Pharmacokinetics of a new carbapenem, DA-1131, after intravenous administration to rats with alloxan-induced diabetes mellitus . Biopharm Drug Dispos , 19 : 303 – 308 .
   PubMed Web of Science ®Google Scholar
• Koren , G , Langevin , A M , Olivieri , N , Giesbrecht , E , Zipursky , A and Greenberg , M . 1990 . Diurnal variation in the pharmacokinetics and myelotoxicity of mercaptopurine in children with acute lymphocytic leukemia . Am J Dis Child , 144 : 1135 – 1137 .
   PubMedGoogle Scholar
• Koren , G , Ferrazzini , G , Sohl , H , Robieux , I , Johnson , D and Giesbrecht , E . 1992 . Chronopharmacology of methotrexate pharmacokinetics in childhood leukemia . Chronobiol Int Dec , 9 : 434 – 438 .
   PubMed Web of Science ®Google Scholar
• Labat , C , Mansour , K , Malmary , M F , Terrissol , M and Oustrin , J . 1987 . Chronotoxicity of methotrexate in mice after intraperitoneal administration . Chronobiologia , 14 : 267 – 275 .
   PubMedGoogle Scholar
• Levi , F A , Hrushesky , W J , Halberg , F , Langevin , T R , Haus , E and Kennedy , B J . 1982 . Lethal nephrotoxicity and hematologic toxicity of cis-diamminedichloroplatinum ameliorated by optimal circadian timing and hydration . Eur J Cancer Clin Oncol , 18 : 471 – 477 .
   PubMedGoogle Scholar
• Lincoln , D W , Hrushesky , W JM and Wood , P A . 2000 . Circadian organization of thymidilate synthase activity in normal tissues: a possible basis for 5-fluorouracil chronotherapeutic advantage . Int J Cancer , 88 : 479 – 485 .
   PubMed Web of Science ®Google Scholar
• Martin , F J , Miguez , J M , Aldegunde , M and Atienza , G . 1995 . Platelet serotonin transport altered in streptozotocin-induced diabetic rats . Life Sci , 56 : 1807 – 1815 .
   PubMed Web of Science ®Google Scholar
• Moon , C H , Lee , H J , Jung , Y S , Lee , S H and Baik , E J . 1998 . Pharmacokinetics of losartan and its metabolite, EXP3174, after intravenous and oral administration of losartan to rats with streptozotocin-induced diabetes mellitus . Res Commun Mol Pathol Pharmacol , 101 : 147 – 158 .
   PubMedGoogle Scholar
• Nadai , M , Yoshizumi , H , Kuzuya , T , Hasegawa , T , Johno , I and Kitazawa , S . 1990 . Effect of diabetes on disposition and renal handling of cefazolin in rats . Drug Metab Dispos , 18 : 565 – 570 .
   PubMed Web of Science ®Google Scholar
• O'Connor , P and Feely , J . 1987 . Clinical pharmacokinetics and endocrine disorders. Therapeutic implications . Clin Pharmacokinet , 13 : 345 – 364 .
   PubMed Web of Science ®Google Scholar
• Park , J M , Moon , C H and Lee , M G . 1996 . Pharmacokinetic changes of methotrexate after intravenous administration to streptozotocin-induced diabetes mellitus rats . Res Commun Mol Pathol Pharmacol , 93 : 343 – 352 .
   PubMedGoogle Scholar
• Peleg , L , Rienstein , S , Ron , I , Dotan , A , Wolfson , S and Ashkenazi , I E . 1998 . Alterations of circadian rhythms in mice induced by anti-cancer drugs . Biol Rhythm Res , 26 : 98 – 104 .
   Google Scholar
• Premaud , A , Rousseau , A , Gicquel , M , Ragot , S , Manceau , J , Laurentie , M and Marquet , P . 2002 . An animal model for the study of chronopharmacokinetics of drugs and application to Methotrexate and Vinorelbine . Toxicol and Applied Pharm , 183 : 189 – 197 .
   PubMed Web of Science ®Google Scholar
• Quesenberry , P , Habibian , H , Dooner , M , McAuliffe , C , Lambert , J F , Colvin , G , Miller , C , Frimberger , A and Becker , P . 2001 . Physical and physiological plasticity of hematopoetic stem cells . Blood Cells Mol Dis , 27 : 934 – 937 .
   PubMed Web of Science ®Google Scholar
• Radziuk , J and Pye , S . 2002 . Quantitation of basal endogenous glucose production in Type II diabetes . Diabetologia , 45 : 1053 – 1084 .
   PubMed Web of Science ®Google Scholar
• Radziuk , J and Pye , S . 2004 . Endogenous glucose production in type 2 diabetes: basal and postprandial, role of diurnal rhythms . J Investig Med , 52 : 379 – 388 .
   PubMed Web of Science ®Google Scholar
• Ramanan , A V , Whitworth , P and Baildam , E M . 2003 . Use of methotrexate in juvenile idiopathic arthritis . Arch Dis Child , 88 : 197 – 200 .
   PubMed Web of Science ®Google Scholar
• Rots , M G , Pieters , R , Peters , G J , Noordhuis , P , van Zantwijk , C H , Kaspers , G JL , Hahlen , K , Creutzig , U , Veerman , A JP and Jansen , G . 1999 . Role of Folylpolyglutamate synthase and folylglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemia . Blood , 93 : 1677 – 1683 .
   PubMed Web of Science ®Google Scholar
• Velasco , A , Huerta , I , Granda , T , Cachero , T G , Menendez , E and Marin , B . 1993 . Circadian rhythms of plasma corticosterone at different times after induction of diabetes. Responses to corticoadrenal stimulation in light and dark phases . Life Sci , 52 : 965 – 974 .
   PubMed Web of Science ®Google Scholar
• Wright , J R , Yates , A J , Shah , N T , Neff , J C , Covey , D W and Thibert , P . 1983 . Hematological characteristics of the BB Wistar rat . Vet Clin Pathol , 12 : 9 – 13 .
   PubMedGoogle Scholar
• Winocour , P D , Kinlough-Rathone , K L and Mustard , J F . 1987 . Platelet survival in rats with spontaneous diabetes mellitus . J Lab Clin Med , 109 : 464 – 468 .
   PubMed Web of Science ®Google Scholar
• Winocour , P D , Laimins , M and Colwell , J A . 1984 . Platelet survival in streptozotocin-induced diabetic rats . Thromb Haemost , 51 : 307 – 312 .
   PubMed Web of Science ®Google Scholar
• Zhao , R , Assaraf , Y G and Goldman , I D . 1998 . A reduced folate carrier mutation produces substrate-dependent alterations in carrier mobility in murine leukemia cells and methotrexate resistance with conservation of growth in 5-formyltetrahydrofolate . J Biol Chem , 273 : 7873 – 7879 .
   PubMed Web of Science ®Google Scholar
• Zhao , R , Gao , F and Goldman , I D . 1999 . Discrimination among reduced folates and methotrexate as transport substrates by a phenylalanine substition for serine within the predicted eight transmembrane domain of the reduced folate carrier . Biochem Pharmacol , 58 : 1615 – 1624 .
   PubMed Web of Science ®Google Scholar
• Zhao , R , Babani , S , Gao , F , Liu , L and Goldman , I D . 2000 . The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate . Clin Cancer Res , 6 : 3687 – 3695 .
   PubMed Web of Science ®Google Scholar